Dahl HHM , Maragos C., Brown RM, et al: Pyruvate dehydrogenase deficiency caused by deletion of a 7-bp repeat sequence in the E1α gene. Am J Hum Genet1990;47:286-293.
2.
Chow CW, Anderson RM, Kenny GCT: Neuropathology in cerebral lactic acidosis. Acta Neuropathol (Berl) 1987;74:393-396.
3.
Michotte A., DeMeirleir L., Lissens W., et al: Neuropathological findings of a patient with pyruvate dehydrogenase E1α deficiency presenting as a cerebral lactic acidosis. Acta Neuropathol (Berl) 1993;85:674-678.
4.
Naito E., Kuroda Y., Takeda E., et al: Detection of pyruvate metabolism disorders by culture of skin fibroblasts with dichloroacetate. Pediatr Res1988;23:561-564.
5.
Wicking CA, Scholem RD, Hunt SM, et al: Immunochemical analysis of normal and mutant forms of human pyruvate dehydrogenase. Biochem J1986;239:89-96.
6.
Sakakihara Y. , Nakamura G., Tokoeda Y., et al: A rapid microassay for dichloroacetate in serum by gel-permeation chromatography. EurJ Clin Chem Clin Biochem1994;32:79-83.
7.
Brown GK: Pyruvate dehydrogenase E1α deficiency. J Inherit Metab Dis1992;15:625-633.
8.
Ho L., Wexler ID, Kerr DS, et al: Genetic defects in human pyruvate dehydrogenase. Ann N YAcad Sci1989;573:347-359.
9.
Brown RM, Dahl HHM, Brown GK: X chromosome localization of the functional gene for the E1 alpha subunit of the pyruvate dehydrogenase complex. Genomics1989;4:171-181.
10.
Dahl HHM , Hunt SM, Hutchinson WM, et al: The human pyruvate dehydrogenase complex. Isolation of cDNA clones for the E1α subunit, sequence analysis, and characterization of the mRNA. JBiol Chem1987;262:7398-7403.
11.
DeMeirleir L., Mackay N., Wah Amlh, et al: Isolation of a full-length complementary DNA coding for human E1α subunit of the pyruvate dehydrogenase complex . J Biol Chem1988;263:1991-1995.
12.
Brown GK, Otero LJ, LeGris M., et al: Pyruvate dehydrogenase deficiency. J Med Genet1994;31:875-879.
13.
Brown RM, Fraser NJ, Brown GK: Differential methylation of the hypervariable locus DXS255 on active and inactive X chromosomes correlates with the expression of a human X linked gene. Genomics1990;7:215-221.
14.
Cremer JE, Teal HM: The activity of pyruvate dehydrogenase in rat brain during postnatal development . FEBS Lett1974;39:17-20.
15.
Kuroda Y., Hu M., Toshima K., et al: Treatment of chronic congenital lactic acidosis by oral administration of dichloroacetate. J Inherit Metab Dis1986 ;9:244-253.
16.
McCormick K. , Viscardi RM, Robinson B., et al: Partial pyruvate decarboxylase deficiency with profound lacticacidemia and hyperammonemia. Am J Med Genet1985;22:291-299.
17.
Wells PG, Moore GW, Rabin D., et al: Metabolic effects and pharmacokinetics of intravenously administrated dichloroacetate in humans. Diabetologia1980 ;19:109-113.
18.
Batalden PB , Van Dyne BJ, Cloyd J.: Pancreatitis associated with valproic acid therapy. Pediatrics1979 ;64:520-522.
19.
Wyllie E., Wyllie R., Cruse RP, et al: Pancreatitis associated with valproic acid therapy. Am J Dis Child1984;138:912-914.
20.
Coulter DL, Allen RJ: Pancreatitis associated with valproic acid therapy for epilepsy. Ann Neurol1980;7:92.
21.
Murphy MJ, Lyon LW, Taylor JW, et al: Valproic acid associated pancreatitis in an adult. Lancet1981;1:41-42.
